Ligand Pharmaceuticals LGND HTM Securities
HTM Securities at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's htm securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ligand Pharmaceuticals's HTM securities?
- Ligand Pharmaceuticals (LGND) reported HTM securities of $588.75M in Q1 2026.
- How has Ligand Pharmaceuticals's HTM securities changed year-over-year?
- Ligand Pharmaceuticals's HTM securities increased by 354.1% year-over-year, from $129.65M to $588.75M.
- What does HTM securities mean?
- Debt securities the company intends and is able to hold until maturity, carried at amortized cost rather than fair value.